Inhibition of the Na+−2Cl−-K+-cotransporter with bumetanide resulted in a significant reduction of ASL height in non-CF cultures to 14.9 ± 1.1 μm (P = 0.002), but had no effect on CF cultures (Fig. 5A). Here, XK is linked to cystic fibrosis.